08.29.24 -- CGT Regulatory Update And Outlook With Dark Horse Consulting

Review the unique set of challenges for RNA production that must be considered and solved to reach their full therapeutic potential.

Single-use tech suppliers must collaborate with advanced therapy manufacturers to mitigate manufacturing risks and ensure chemical composition meets safety and efficacy standards.

Examine the evolving landscape of cell and gene therapies, with a focus on expanding access, especially for treating solid tumors outside traditional academic settings.

Identifying critical factors and their concentrations with an eye towards designing an ideally formulated, defined serum-free medium should be carried out using rational and systematic approaches.

Expand your knowledge on the latest innovation in the sterile connector space including the new 1.5” flow path connector, disconnection solution, and more.

Accelerate essential process development activities with instrumentation solution allowing for highly reproducible and scalable production of RNA-LNPs.

Explore this study that works to determine the optimal concentrations of IL-7 and IL-15 for T cell expansion, as well as how to produce the desired phenotype while requiring less protein.

Mesenchymal stem cells have been used to show equivalent expansion kinetics during a 7-day expansion protocol on both the small and standard bioreactors revealing efficiency differences.

Discover how years of experience bolstered by continuous improvement efforts, enable hybrid clinical trial execution, from in-home clinical visits to site networks and digital platforms and technology.

Uncover how this system can automate several steps of your cell therapy workflow while achieving high efficiency, how to optimize cell recovery during harvesting, and more.

Better understand the forces behind digital transformation, and learn how a new manufacturing excellence platform can be used to achieve real-time process transparency and insights.

This study evaluates the performance of a flexible, automated fixed bed reactor (FBR) system during AAV production, comparing it with a similar FBR system and 2D cell culture controls.